Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-23-020508

Chief Executive Officer bought 7,000 shares at $1.42 ($9,940)

From the SEC's structured data for this filing

Trades in this filing

Fried Robert N · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-05-31 Purchase : show line 1 in the form +7,000 $1.42 $9,940 95,001 I
Open-market purchases · 7,000 sh · avg $1.42 · $9,940
Loading xslF345X04/wk-form4_1685651259.xml…